What do personalized medicine, new materials, biologization, digitalization and miniaturization in medical technology have in common? The UAS impulse partnership Connected Health in Medical Mountains
Epitope Mapping Dr. Anne Zeck Group Leader Bioanalytics +49 7121 51530-811 E-Mail anzeigen Verification and determination of the exact binding region of antibodies by HDX-LC-MS We offer characterizati
Testing the identity, integrity and labeling level of recombinant proteins Dr. Anne Zeck Group Leader Bioanalytics +49 7121 51530-811 E-Mail anzeigen Analysis of intact proteins by mass spectrometry W
Determination of the thermal stability (Tm) of proteins using nanoDSF Dr. Anne Zeck Group Leader Bioanalytics +49 7121 51530-811 E-Mail anzeigen Thermal stability is an important parameter in the sele
For the detection of biomarkers, specific tests are often required for different model organisms in order to be able to record the effects or side effects of biologically active substances (drug candi
Multi-Pathogenic Serology Dr. Nicole Schneiderhan-Marra Head of Pharma & Biotech +49 7121 51530-815 E-Mail anzeigen Determining antibody status post-infection or post-vaccination Serological immmunoas
Target Research Target Research comprises of the identification and validation of a target’s potential therapeutic or diagnostic benefit. By offering lead identification and optimization methods as we
Recently updated COVID-19 mRNA vaccines encode the spike protein of the omicron subvariant XBB.1.5 and are recommended for patients with inflammatory bowel disease (IBD) on immunosuppressive treatment
The Fiber4Ink project partners meet every six months to exchange ideas. Today, they discussed the current project status at the NMI. How is Fiber4Ink progressing? The project partners meet every six m
